QQ客服 官方微博 反馈留言

	CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis
	Zhou, Ye; Wang, Xue-bin; Qiu, Xue-ping; Zhang, Shuai; Wang, Chen; Zheng, Fang
刊名	CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
	2018
卷号	42期号:6
关键词	Methylation CDKN2A Hepatocellutar carcinoma Meta-analysis
ISSN号	2210-7401
DOI	10.1016/j.clinre.2017.07.003
URL标识	查看原文
收录类别	SCIE
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4154425
专题	武汉大学
推荐引用方式 GB/T 7714	Zhou, Ye,Wang, Xue-bin,Qiu, Xue-ping,et al. CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis[J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY,2018,42(6).
APA	Zhou, Ye,Wang, Xue-bin,Qiu, Xue-ping,Zhang, Shuai,Wang, Chen,&Zheng, Fang.(2018).CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis.CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY,42(6).
MLA	Zhou, Ye,et al."CDKN2A promoter methylation and hepatocellular carcinoma risk: A meta-analysis".CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY 42.6(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。